Failure of Antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis

Stroke

Volumn 40, Issue 2, 2009, Pages 505-509

  Turan, Tanya N ^a,e   Maidan, Lucian ^b   Cotsonis, George ^b   Lynn, Michael J ^b   Romano, Jose G ^c   Levine, Steven R ^d   Chimowitz, Marc I ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anticoagulation; Antiplatelet; Cerebral arteries; Cerebrovascular disease; Intracranial stenosis

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BASILAR ARTERY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; HAZARD RATIO; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERY STENOSIS; BIOASSAY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; STENOSIS, OCCLUSION AND OBSTRUCTION; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ASPIRIN; CEREBROVASCULAR DISORDERS; CONSTRICTION, PATHOLOGIC; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 60549109654     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.528281     Document Type: Article

References (9)

1. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction:the Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
2. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS. Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
3. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis:outcome of patients who fail antithrombotic therapy. Neurology. 2000;55:490-498.
4. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003;22:106-117.
5. Lin D, Wei L, Ying Z. Checking the Cox model with cumulative sums of Martingale-based residual. Biometrika. 1993;80:557-572.
6. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P;Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
7. Mohr JP. Evidence of aspirin and warfarin failure in the WARSS Study. Platform presentation at 27th International Stroke Conference;San Antonio, TX;February 2002.
8. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses:the Wingspan study. Stroke. 2007;38:1531-1537.
9. Kasner SE, Chimowitz MI, Lynn, MJ Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ, for the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.